AAAAAA
Results:
1-15
|
Results: 15
Authors:
KRUSE CA
VARELLAGARCIA M
KLEINSCHMIDTDEMASTERS BK
OWENS GC
SPECTOR EB
FAKHRAI H
SAVELIEVA E
LIANG BC
Citation: Ca. Kruse et al., RECEPTOR EXPRESSION, CYTOGENETIC, AND MOLECULAR ANALYSIS OF 6 CONTINUOUS HUMAN GLIOMA CELL-LINES, In vitro cellular & developmental biology. Animal, 34(6), 1998, pp. 455-462
Authors:
FAKHRAI H
SHAWLER DL
VANBEVEREN C
LIN H
DORIGO O
SOLOMON MJ
GJERSET RA
SMITH L
BARTHOLOMEW RM
BOGGIANO CA
GOLD DP
SOBOL RE
Citation: H. Fakhrai et al., CONSTRUCTION AND CHARACTERIZATION OF RETROVIRAL VECTORS FOR INTERLEUKIN-2 GENE-THERAPY, Journal of immunotherapy, 20(6), 1997, pp. 437-448
Authors:
SHAWLER DL
DORIGO O
VANBEVEREN C
BARTHOLOMEW RM
FAKHRAI H
SOBOL RE
Citation: Dl. Shawler et al., INTERLEUKIN-2 (IL-2) GENE-THERAPY WITH ALLOGENEIC FIBROBLASTS IN THE CT-26 MODEL OF MURINE COLORECTAL-CARCINOMA, Oncology Reports, 4(1), 1997, pp. 135-138
Authors:
FAKHRAI H
Citation: H. Fakhrai, STOP MAKING SENSE, Trends in genetics, 13(6), 1997, pp. 214-214
Authors:
FAKHRAI H
DORIGO O
FREDIEU A
SHAWLER DL
SOBOL RE
BLACK KL
Citation: H. Fakhrai et al., TRANSFORMING GROWTH FACTOR-B (TGF-B) ANTISENSE GENE-THERAPY OF GLIOBLASTOMA-MULTIFORME (GBM), The FASEB journal, 10(6), 1996, pp. 2384-2384
Authors:
FAKHRAI H
DORIGO O
SHAWLER DL
LIN H
MERCOLA D
BLACK KL
ROYSTON I
SOBOL RE
Citation: H. Fakhrai et al., ERADICATION OF ESTABLISHED INTRACRANIAL RAT GLIOMAS BY TRANSFORMING GROWTH-FACTOR-BETA ANTISENSE GENE-THERAPY, Proceedings of the National Academy of Sciences of the United Statesof America, 93(7), 1996, pp. 2909-2914
Authors:
POTAPOVA O
FAKHRAI H
MERCOLA D
Citation: O. Potapova et al., GROWTH-FACTOR PDGF-B V-SIS CONFERS A TUMORIGENIC PHENOTYPE TO HUMAN TUMOR-CELLS BEARING PDGF RECEPTORS BUT NOT TO CELLS DEVOID OF RECEPTORS- EVIDENCE FOR AN AUTOCRINE, BUT NOT A PARACRINE, MECHANISM/, International journal of cancer, 66(5), 1996, pp. 669-677
Authors:
POTAPOVA O
FAKHRAI H
BAIRD S
MERCOLA D
Citation: O. Potapova et al., PLATELET-DERIVED GROWTH FACTOR-B V-SIS CONFERS A TUMORIGENIC AND METASTATIC PHENOTYPE TO HUMAN T98G GLIOBLASTOMA CELLS/, Cancer research, 56(2), 1996, pp. 280-286
Authors:
GJERSET RA
FAKHRAI H
SHAWLER DL
TURLA S
DORIGO O
GROVERBARDWICK A
MERCOLA D
WEN SF
COLLINS H
LIN H
GARCIA MV
KRUSE CA
ROYSTON I
SOBOL RE
Citation: Ra. Gjerset et al., CHARACTERIZATION OF A NEW HUMAN GLIOBLASTOMA CELL-LINE THAT EXPRESSESMUTANT P53 AND LACKS ACTIVATION OF THE PDGF PATHWAY, In vitro cellular & developmental biology. Animal, 31(3), 1995, pp. 207-214
Authors:
SHAWLER DL
DORIGO O
GJERSET RA
ROYSTON I
SOBOL RE
FAKHRAI H
Citation: Dl. Shawler et al., COMPARISON OF GENE-THERAPY WITH INTERLEUKIN-2 GENE MODIFIED FIBROBLASTS AND TUMOR-CELLS IN THE MURINE CT-26 MODEL OF COLORECTAL-CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 17(4), 1995, pp. 201-208
Authors:
FAKHRAI H
SHAWLER DL
GJERSET R
NAVIAUX RK
KOZIOL J
ROYSTON I
SOBEL RE
Citation: H. Fakhrai et al., CYTOKINE GENE-THERAPY WITH INTERLEUKIN-2-TRANSDUCED FIBROBLASTS - EFFECTS OF IL-2 DOSE ON ANTITUMOR IMMUNITY, Human gene therapy, 6(5), 1995, pp. 591-601
Authors:
SOBOL RE
ROYSTON I
FAKHRAI H
SHAWLER DL
CARSON C
DORIGO O
GJERSET R
GOLD DP
KOZIOL J
MERCOLA D
VANBEVEREN C
WILSON D
Citation: Re. Sobol et al., INJECTION OF COLON-CARCINOMA PATIENTS WITH AUTOLOGOUS IRRADIATED TUMOR-CELLS AND FIBROBLASTS GENETICALLY-MODIFIED TO SECRETE INTERLEUKIN-2 (IL-2) - A PHASE-I STUDY, Human gene therapy, 6(2), 1995, pp. 195-204
Authors:
SOBOL RE
FAKHRAI H
SHAWLER D
GJERSET R
DORIGO O
CARSON C
KHALEGHI T
KOZIOL J
SHIFTAN TA
ROYSTON I
Citation: Re. Sobol et al., INTERLEUKIN-2 GENE-THERAPY IN A PATIENT WITH GLIOBLASTOMA, Gene therapy, 2(2), 1995, pp. 164-167
Authors:
RIBAS A
FAKHRAI H
SHAWLER D
SOBOL R
BELLMUNT J
SOLE LA
Citation: A. Ribas et al., TRANSDUCTION AND SELECTION OF MURINE TUMOR-CELLS ENGINEERED TO EXPRESS THE INTERLEUKIN-2 (IL-2) AND HERPES-SIMPLEX VIRUS THYMIDINE KINASE (HSVTK) GENES, European journal of cancer, 31A, 1995, pp. 1277-1277
Authors:
SOBOL RE
DORIGO O
SHAWLER DL
LIN H
ROYSTON I
FAKHRAI H
Citation: Re. Sobol et al., IMMUNO-GENE THERAPY OF RAT GLIOMA WITH TGF-BETA-2 ANTISENSE AND IL-2 GENE MODIFIED TUMOR-CELLS, European journal of cancer, 31A, 1995, pp. 31-31
Risultati:
1-15
|